The financials
Cardinal Health by the numbers
Cardinal Health (CAH) reported revenue of $124.6B in H2 2026 (quarter ended June 30, 2026), up 127% from the same quarter a year earlier. That came with a gross margin of 4.1% and net income of $797M (0.6% of revenue). For the full year FY2026, revenue was $254.2B (+14% year on year) and net income $1.71B. Its largest segment in 2026-Q1 was Pharmaceutical And Specialty Solutions at $56.1B, 94% of the disclosed total, just ahead of GMPD at 5.3%.
| Income statement | H2 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $124.6B | $54.9B | +127% |
| Gross profit | $5.06B | $2.12B | +138% |
| Operating income | $1.24B | $730M | +70% |
| Net income | $797M | $506M | +58% |
| Diluted EPS | n/a | $2.10 | n/a |
| Operating | Revenue | Share |
|---|---|---|
| Pharmaceutical And Specialty Solutions | $56.1B | 94% |
| GMPD | $3.15B | 5.3% |
| All Other | $478M | 0.8% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q1 2026Total $59.74B (-7.2%)
All Other grew +19% year on yearGMPD -0.38% year on year
Segment Latestquarter on quarteryear on year
- Pharmaceutical And Specialty Solutions$56.11B$56.11BQoQ -7.5%year on year +11%-7.5%+11%
- GMPD$3.15B$3.15BQoQ -3.4%year on year -0.38%-3.4%-0.38%
- All Other$478.0M$478.0MQoQ +8.6%year on year +19%+8.6%+19%
Healthcare
Ranks #70 of 345 by Smart Score